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ABSTRACT 
Temporomandibular joint disorders (TMD) is a debilitating orofacial pain condition that 
affects a significant portion of the population and is associated with a decrease in quality 
of life. Results from the Orofacial Pain Prospective Evaluation and Risk Assessment 
Study (OPPERA) study provide evidence that risk factors such as neck muscle tension, 
prolonged jaw opening, and female gender increase the likelihood of developing TMD. 
Routine visits to an orthodontist or dentist can result in injury to the jaw joint or muscles 
of mastication. I tested the hypothesis that neck muscle inflammation and female gender 
increase the risk of developing chronic pain in response to prolonged jaw opening. Young 
male Sprague-Dawley rats were injected with complete Freund’s adjuvant in the 
trapezius muscle to promote sensitization of trigeminal ganglion neurons. After 8 days, 
both male and female animals were subjected to near maximal jaw opening for 20 
minutes. Mechanical nocifensive thresholds were determined in response to von Frey 
filaments applied to the skin over the eyebrow, masseter muscle, and joint capsule.  Near 
maximal jaw opening increased nocifensive responses to mechanical stimuli over the 
masseter area for 14 days but then returned to near baseline levels by day 21.  However, 
muscle inflammation prior to jaw opening resulted in prolonged nociception that was 
observed up to 28 days post jaw opening.  Our findings provide evidence that neck 
muscle inflammation promotes sensitization of trigeminal neurons such that prolonged 
jaw opening causes a sustained nocifensive response that was more severe in females.   
 
 
KEYWORDS:  trigeminal nerve, temporomandibular joint disorder, peripheral 
sensitization, central sensitization, risk factors. 
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 1 
INTRODUCTION 
                     
Orofacial Pain                                                                              
Orofacial pain is defined as pain associated with hard and soft tissues of the head, 
face, and neck regions. One of the most common causes of orofacial pain is toothache, 
which is reported to occur in 12.2% of the population Boggero et al. (2016). 
Temporomandibular joint pain was reported by 5.3% and face or cheek pain being 
reported by 1.4%. Many conditions co-exist with temporomandibular joint disorder like 
fibromyalgia, chronic fatigue syndrome, headache, panic disorder, and irritable bowel 
syndrome (Aaron et al., 2000, Bevilaqua Grossi et al., 2009, Ohrbach et al., 2011b, 
Dahan et al., 2015).  It is estimated that a third of the population in the nation suffers 
from chronic pain. Chronic pain usually results in billions of dollars spent annually for 
health care services, loss of work, decreased productivity, and disability compensation. 
There is decreased satisfaction with life seen in patients with orofacial pain because this 
pain negatively affects their physical, emotional, and social functioning (Carlson et al., 
1998, De Leeuw et al., 2005, Boggero et al., 2016).  The mental health status of these 
patients will affect the pain experience and conditions like depression and anxiety are 
often co-morbid in these individuals.  There are certain neural markers for fear and 
anxiety that aggravate chronic pain and add to the disease burden (Zakrzewska, 2013). 
The clinician responsibility for treating patients with TMD is threefold.  Firstly, 
they must ask appropriate questions and try to get certain information from the patients. 
Based on the responses, they should try analyzing and understanding the pathology based 
on their knowledge of basic and clinical science of orofacial pain. Secondly, a thorough 
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clinical assessment needs to be performed including physical and laboratory testing. 
Third, all the findings from the tests must be clearly explained and the treatment options 
should be clearly presented to the patient, which must be consistent with the standards of 
care based on the scientific literature.  As reported by the National Institutes of Dental 
and Craniofacial Research (NIDCR), temporomandibular joint disorders are the most 
prevalent orofacial pain conditions for which patients seek treatment and are typically 
difficult to treat because of their complex pathophysiology.   
 
 
Temporomandibular Joint Disorders 
Temporomandibular disorders (TMD), a chronic disease that affects between 5-
12% of the adult population, is characterized by pain in the temporomandibular joint 
(TMJ) or jaw joint and the muscles associated with mastication (Poveda Roda et al., 
2007, Greenspan et al., 2011a, Ohrbach et al., 2011b, Furquim et al., 2015).  TMD affects 
both men and women with the incidence of pain highest during adolescence (Bonjardim 
et al., 2009), and individuals often exhibit increased sensitivity to other experimentally 
induced pains (Maixner et al., 1995, Maixner et al., 1998).  Temporomandibular joint 
disorders (TMJD) are those that affect the joint more than the muscles. They are 
commonly associated with trauma and are unilateral conditions. The signs of TMJD are 
seen in about 60–70% of the general population but only one in four people with signs 
are actually aware of it. Some of the common symptoms associated with these are 
clicking, tinnitus, headaches, and limited range of motion (Bevilaqua Grossi et al., 2009). 
There are many diseases and medical problems that are reported more common in women 
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in the clinical population.  Not too surprisingly, the ratio between women and men who 
seek treatment for the TMJ is 8:1 (Sharma et al., 2011).  
 Approximately 6 to 12% of the adult United States population suffers from TMD. 
Among these patients, 80% show signs and symptoms of joint diseases including disc 
displacement, arthralgia, and osteoarthritis (Park et al., 2015).  Patients with TMD 
usually present symptoms of more neck pain besides pain in the craniomandibular region. 
Through central command or reflex connectivity between the anatomical areas, disease in 
one system results in pain or dysfunction of another system (Ries et al., 2014). The 
pathological pain associated with TMD involves activation of trigeminal ganglion nerves, 
which provide sensory innervation of the head and face and relay nociceptive signals to 
the spinal trigeminal nucleus (STN) (Bereiter et al., 2005, Shimizu et al., 2009, Sessle, 
2011).  During TMD dysfunction, inflammatory molecules including cytokines, 
calcitonin-gene related peptide (CGRP), and the excitatory amino acid glutamate are 
released from the nerve terminals in the peripheral tissues to promote neurogenic 
inflammation (Sessle, 2011). There are three main effects characteristic of neurogenic 
inflammation which include increased blood flow, increased endothelial permeability, 
and recruitment and activation of key immune cells.  The rise in CGRP and glutamate 
levels activates peripheral RAMP1 and N-methyl-D-aspartate (NMDA) receptors, 
respectively, that are located on afferent trigeminal neurons innervating deep tissues of 
both the joint and muscle tissues (Lennerz et al., 2008, Benemei et al., 2009, Cady et al., 
2011, Cornelison et al., 2016). Stimulation of these peripheral receptors promotes a 
prolonged inflammatory response to facilitate healing and also transmits nociceptive 
signals to the upper spinal cord to cause pain, which helps to protect the tissues by 
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inhibiting their use.  This type of physiological response to injury or infection leads to the 
development of peripheral and central sensitization of trigeminal neurons that persists 
until the tissues are healed (Cheng and Ji, 2008, Ren and Dubner, 2008, Ji et al., 2009, 
Sessle, 2011).  However, in some cases, this sensitized state can persist leading to a 
pathophysiological state characterized by increased pain (hyperalgesia) and sensitivity to 
non-noxious stimuli (allodynia) that does not serve a protective or healing function.   
 
Risk Factors for TMD 
Multiple risk factors have been identified that promote the development of TMD, 
which are prevalent chronic orofacial pain conditions often associated with a significant 
decrease in quality of life.  Results from the OPERRA study provide evidence that 
prolonged jaw opening, neck muscle tenderness, and female gender are commonly 
reported risk factors associated with the development of TMD (Greenspan et al., 2011a).  
Paradoxically, routine visits to the dentist for molar extractions or root canals, or to the 
orthodontist can result in an injury to the TMJ or muscles of mastication if the jaw is held 
open for prolonged periods of time or is opened to 100% of maximum even for a short 
period of time (e.g. yawning).  Mechanical overloading of the TMJ is a causative factor 
in the onset of osteoarthritis and related orofacial pain disorders (Nicoll et al., 2010).  
With respect to TMD, female prevalence is more than twice that of males, yet the reason 
for this difference is not well understood.   
There is emerging evidence in many complex neurological diseases that anxiety 
greatly influences disease onset, progression, and maintenance of the clinical phenotype 
(Ohrbach and Dworkin, 1998, Buse et al., 2013).  The pathophysiological effects of 
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unmanaged anxiety can include increased tension in the muscles of the neck and 
shoulders especially in females (Ohrbach and Dworkin, 1998).  Based on 
immunohistochemical studies, skeletal muscles are predominantly innervated by CGRP-
containing neurons that facilitate pain signal transmission to the spinal cord (Tsukagoshi 
et al., 2006, Dudek et al., 2011, Barry et al., 2015).  Thus, chronic muscle overload and 
tension in the neck and shoulders can lead to persistent fiber contraction, local ischemia, 
and the release of pro-inflammatory mediators, including CGRP, which can promote 
sensitization and activation of primary nociceptors (Greenspan et al., 2011b).  Excitation 
of nociceptive neurons, which occurs in response to tonic muscle activity associated with 
myogenic trigger points, can lead to hypersensitization and lower pain thresholds of 
second order nociceptive neurons characteristic of central sensitization (Graven-Nielsen 
and Arendt-Nielsen, 2002).  In addition, CGRP levels were reported to be elevated in 
myogenic trigger points, which are described as ‘a hyperirritable spot in skeletal muscle 
that is associated with a hypersensitive palpable nodule in a taut band’’ (Hong and 
Simons, 1998, Shah and Gilliams, 2008).  Convergence in the upper spinal cord of nerves 
providing sensory innervation of the neck and shoulder muscles and those emanating 
from the trigeminal ganglion may help to explain why neck and shoulder pathology is 
often associated with orofacial pain conditions including TMJD (Sessle, 1999, Bartsch 
and Goadsby, 2003, Morch et al., 2007).  Elevated levels of CGRP in the spinal cord, as 
can occur in response to prolonged muscle inflammation in the neck (unpublished data 
from our laboratory), are implicated in the development of central sensitization and a 
prolonged state of neuronal sensitization (Seybold, 2009, Cornelison et al., 2016).  In 
sum, these findings support a fundamental role of neck muscle tension in promoting the 
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development of a more persistent sensitized state of trigeminal primary and secondary 
nociceptive neurons characteristic of TMD.  Disability associated with jaw and neck pain 
interferes greatly with daily activities and can have a negative impact on a patient’s 
lifestyle by diminishing an individual’s ability to work and interact in a social 
environment (Silveira et al., 2015).    
 
Anatomy of Temporomandibular Joint 
 Temporomandibular joint (TMJ) is a sliding hinge that connects the jawbone to 
skull (Fig. 1).   It is a bilateral synovial articulation between the mandible and temporal 
bone. The TMJ and its corresponding structures play a major role in guiding mandibular 
motion and in daily tasks such as chewing, swallowing, and speaking by distributing the 
mechanical stresses (Murphy et al., 2013).  The capsule is a dense fibrous membrane that 
surrounds the TMJ. The joint capsule is lined by a synovial membrane which contains the 
synovial fluid and has a lateral ligamentous thickening that is the temporomandibular 
ligament (Shaffer et al., 2014).  The articular surface is a fibrous extension of the capsule, 
which is a distinctive structure of the temporomandibular joint. The articular disc is a 
round, biconcave, avascular fibrocartilage structure that is located between the condyle 
and glenoid fossa (Bag et al., 2014). The articular disc divides the TMJ into two 
compartments namely upper and lower joint compartments, which are synovial cavities. 
The lower joint compartment formed between the mandible and articular disc is involved 
in rotational movement. The upper joint compartment formed between articular disc and 
temporal bone is involved in translational movement.  Anterior to the glenoid fossa and 
medial to the posterior margin of the zygomatic process is articular eminence.   
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The movement and stability of the TMJ is provided by the musculature of the 
head, face, and cervical spine.  The muscles of mastication which include masseter, 
temporalis, medial pterygoid and lateral pterygoid are the primary muscles of the cranial 
facial area that are involved in the jaw opening and closing, protrusion and retraction, as 
well as the lateral movements of the mandible (Shaffer et al., 2014).  Muscles of 
mastication and other accessory muscles generally help the opening and closing of the 
jaw (Bag et al., 2014).  One of the most powerful muscles of mastication is the masseter 
muscle.  It has two parts namely, superficial and deep. The superficial originates from the 
zygomatic process of the maxillary bone and the deep part originates from the zygomatic 
arch of the temporal bone. Both parts attach to the zygomatic arch of the temporal bone. 
They play a role in the closing of the mouth or elevating the mandible. The Temporalis is 
another powerful muscle of the TMJ that arises from the temporal fossa, which is a 
shallow depression on the lateral aspect of the skull. It inserts into the coronoid process of 
the mandible.  Together with the masseter, the temporalis muscle helps in elevating the 
mandible and closing of the mouth. The mandibular nerve (V3) branch of the trigeminal 
nerve innervates these two muscles. 
 The other muscles, which are innervated by the trigeminal nerve, are the lateral 
and the medial pterygoid muscles. The lateral pterygoid muscle is a triangular shape 
muscle that has two heads namely superior and inferior. The superior head originates 
from the greater wing of the sphenoid and the inferior head from the lateral pterygoid 
plate of the sphenoid. Both of them attach into the neck of the mandible.  Since, it has 
horizontally oriented muscle fibers, thus it is the major protractor muscle of the mandible. 
The lateral pterygoid muscle acts bilaterally to cause the protraction of the mandible or 
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forward movement, and acts unilaterally to produce side-to-side movement of the jaw. 
Located inferior to the lateral pterygoid muscle is the medial pterygoid, a quadrangular 
shaped muscle possessing deep and superficial heads. These attach to the ramus of the 
mandible, near the angle of the mandible and help in elevating the mandible. 
 
Trigeminal System and Nociception  
        Sensory innervation of the TMJ and associated muscles of mastication is provided 
by the Trigeminal or fifth cranial nerve that originates from the lateral border of the pons 
through the sensory and motor roots (Shankland, 2000).  There are three branches of the 
trigeminal nerve namely, Ophthalmic, Maxillary and Mandibular divisions that provide 
sensory innervation to different areas of the face and neck tissues (Fig. 2).  The 
Ophthalmic branch is purely sensory and innervates the scalp, skin of the eyebrows, 
eyelids, forehead, nose, tentorium cerebelli, posterior falx cerebri and dura mater 
(Shankland, 2001a). The disorders primarily associated with this branch are headaches 
and migraine. The Maxillary nerve is intermediate in size and it gives sensory innervation 
to all structures in and around the maxillary bone and the midfacial region (Shankland, 
2001b). That includes the skin of the midfacial regions, lower eyelid, side of nose and 
upper lip, the mucous membrane of the nasopharynx, maxillary sinus, soft palate, palatine 
tonsil, roof of the mouth, maxillary gingivae, and maxillary teeth.  Disorders involving 
this branch include rhinosinusitis and trigeminal neuralgia.  The largest branch among 
these three is the mandibular branch that is a mixed nerve, meaning that there are both 
sensory and motor roots (Shankland, 2001c). The sensory root innervates the skin of the 
temporal region and lower third of the face, lower lip, and ear, the mucous membrane of 
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the anterior two-thirds of the tongue and mouth floor, the muscles of the first brachial 
arch, and the teeth and gingivae of the mandible .  The small motor root supplies efferent 
innervation to the muscles of the first brachial arch that consist of the muscles of 
mastication, the tensors veli palatini and tympani, the mylohyoid muscle, and anterior 
belly of the digastrics muscle.  The mandibular nerve relays chemical, mechanical, and 
thermal information from peripheral head and face tissues to the central nervous system.  
The cell bodies from which all trigeminal nerve fibers originate are located in the 
trigeminal ganglion (TG).  The neurons of this nerve are pseudounipolar, which means 
that this neuron contains a conducting process that has split into two branches. One 
branch, the afferent, terminates in the periphery and the other branch, the efferent, 
projects to the upper spinal cord (Devor, 1999, Durham, 2016).  The two main types of 
sensory neurons are Large Light (LL) and Small Dark (SD).  Large light neurons gives 
rise to Aδ fibers, which are myelinated and fast conducting. Small dark neurons give rise 
to non-myelinated C fibers that transmit signals more slowly and for a longer duration. 
The TG contain two types of supporting glial cells, namely Schwann cells and satellite 
glial cells (Hanani, 2005).  Schwann cells play an important role in the production of the 
myelin sheath that surrounds the axons and increase the conduction velocity of the nerve. 
The Satellite glial cells have a major modulatory role in influencing the excitability state 
of the neurons in response to peripheral stimuli (Durham and Garrett, 2010, Durham, 
2016).  Thus, primary trigeminal nerves provide a pathway for transmission of 
information mediated by peripheral stimuli, including thermal, mechanical, and chemical, 
to the upper spinal cord region known as the spinal trigeminal nucleus.   
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Nociception is encrypting and processing of harmful stimuli in the nervous 
system and therefore protecting itself from potential harm. The nociceptors are 
specialized peripheral sensory neurons that detect intense stimuli and provide the first 
line of defense against any potential damage. They are thin myelinated, fast acting (A-δ) 
fibers or slow acting unmyelinated C fibers that form the majority of the sensory neurons 
in the peripheral nervous system (Woolf and Ma, 2007). Inflammation of peripheral 
tissues may be associated with the release of chemical mediators like histamine and 
tumor necrosis factor from the tissue cells such as mast cells, macrophages, and other 
immune cells. Nociception caused by a harmful stimuli can trigger nociceptive reflexes at 
the sight of pain (Sessle, 2008). These reflexes are protective behaviors that can be 
observed as avoidance behaviors or withdrawal behaviors, and result in the removal of 
the affected body part from the stimuli.  The classic example of this is the hand 
withdrawal-reflex from a hot stove. Similar behaviors can be observed from other types 
of noxious stimuli to protect tissues located in the stimulated area.  
During inflammation or injury, there is an activation of primary nociceptors and 
decrease in the activation threshold resulting in peripheral sensitization (Sessle, 2011). 
This results in an increase in glutamate levels and other excitatory molecules in the spinal 
trigeminal nucleus. These mediators can cause sustained excitation of second order 
neurons that promotes increased spontaneous neuronal firing and a lower threshold of 
activation characteristic of central sensitization.  Development of peripheral and central 
sensitization results in hyperalgesia and allodynia, which are pathophysiological features 
seen in individuals suffering from chronic pain pathologies like TMD.  
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Hypothesis and Goals of Thesis Research 
There are a number of animal models that mimic human clinical conditions. 
Chronic pain conditions are established using an emulsion of heat- killed Mycobacterium 
tuberculosis known as complete Freund’s adjuvant (Sato et al., 2005, Takeda et al., 
2005).  Routine dental visits for molar extractions or root canals can result in the injury to 
the TMJ or muscles of mastication.  Previous studies showed that CFA or prolonged jaw 
opening increased nocifensive responses to mechanical stimuli over the masseter area for 
14 days but then returned to near baseline levels by day 21 (Garrett et al., 2012, Hawkins 
and Durham, 2016).  Based on the findings from the OPERRA study, which was the first 
large prospective study done on humans to identify the psychological and physiological 
risk factors that lead to development of TMD, I wanted to test my hypothesis that the risk 
factors, neck muscle inflammation and female gender, would promote persistent 
sensitization of trigeminal neurons leading to a more chronic orofacial pain condition in 
response to prolonged jaw opening. 
To test my hypothesis, I propose the following goals: 
1. To determine the effect of neck muscle inflammation on the nocifensive 
behavioral response to prolonged jaw opening in three different orofacial regions 
including the cutaneous tissue above the eyebrow, masseter, and TMJ. 
 
2. To compare the nocifensive withdrawal responses to mechanical stimuli in males 
and females in three different orofacial regions in sensitized animals. 
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Fig. 1. Anatomy of the Temporomandibular Joint (A) Diagram displaying a lateral view 
of the joint including supporting ligaments and processes. (B) Cross-sectional view 
revealing the articular disk and joint cavities. (C) Diagram showing the various muscles 
associated with the TMJ.  http://www.edu.womenshealtharizona.com. 
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Fig. 2. Anatomy of the Trigeminal Ganglion. (A) Illustration of the location of the 
trigeminal nerves and trigeminal ganglion. http://www.frca.co.uk  (B) A cross-section of 
the trigeminal ganglion stained with the nuclear dye DAPI to identify the three main 
branches. (C) A 400x image of DAPI-stained tissue showing nucleus of the neuronal cell 
body, surrounded by satellite glia cells. Also shown are Schwann cells, which are 
associated with axons. (D) A diagram illustrating a psuedounipolar trigeminal neuron, 
which provides a pathway to transmit sensory information from the peripheral tissues to 
the central nervous system (CNS). 
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MATERIAL AND METHODS 
 
 
 
Animals and Reagents 
Animal protocols were approved by the Institutional Animal Care and Use 
Committee at Missouri State University (IACUC ID: 17.001.0) and conducted in 
compliance with all guidelines established by the National Institutes of Health Animal 
Welfare Act. An effort was made to reduce suffering and number of animals used in the 
study. Adult male Sprague-Dawley rats (350-500g) and female Sprague-Dawley rats 
(250-300g) were purchased from Charles River Laboratories Inc. (Wilmington, MA) or 
purchased from Missouri State University (internal breeding colonies). Animals were 
housed in clean, plastic cages (VWR, West Chester, PA) in an animal holding room 
maintained at ambient temperature (22-24°C) with access to food and water ad libitum. 
The holding room was on a 12-hour light/dark cycle starting at 7 A.M. These animals 
were allowed to acclimate in this environment for at least 1 week upon arrival prior to 
use.  Complete Freud’s adjuvant (CFA, Sigma Aldrich) was prepared as a 1:1 emulsion in 
0.9% saline solution (Fisher-Scientific) immediately prior to use.  
 
Model of TMD 
 Neck muscle inflammation, which results in a hyperirritable spot in skeletal 
muscle that is associated with a hypersensitive palpable nodule in a taut band (“trigger 
point”) will be induced by administering complete Freud’s adjuvant (CFA) or saline 
bilaterally into the neck muscle of young adult Sprague Dawley male and female rats. 
The animals were anesthetized with 5% isoflurane (Webster Veterinary, Devens, MA) 
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using oxygen as the carrier gas and a Vetequip isoflurane mixing apparatus connected to 
the animal chamber. Once anesthetized, animals were placed ventral surface down, and 
attached to a nose cone apparatus delivering a steady flow of 3 % isoflurane. The final 
volume injected was a total 100 µL CFA (50 µL bilaterally) and applied as micro-
injections containing 10 µL each (Fig. 3). 
 
In preparation of mechanically induced injury to the TMJ and associated muscles, 
ligaments, and tendons, animals were anesthetized via inhalation of 5% of Isoflurane and 
then were placed dorsal side down and attached to a nose cone apparatus delivering a 
steady flow of 3% isoflurane.  A mouth retractor (Fine Scientific Tools, Foster City, CA), 
was positioned around the bottom and top incisors. The retractor arms were then 
separated until the desired percentage of opening was reached and held at near maximum 
incisor opening for 20 minutes (Fig. 4). Opening measurements were taken from the 
gingival line on the lingual surface of the upper incisors to the gingival line on the lingual 
surface of the lower incisor by utilization of a CaliMax Vernier Caliper (Wiha Tools, 
Montecillo, MN). It was determined that, on average, the maximum opening capacity 
without subluxation of the joint was approximately 22 mm in young adult male Sprague-
Dawley rats and 20 mm in young adult female Sprague-Dawley rats. To allow for 
consistency between experiments, this measurement was used as a standard opening 
measurement throughout the experiment. Once the retractor was placed at the standard 
opening measurement, the animal was returned to the animal chamber attachment and 
maintained at 3% isoflurane for the duration of stress application.  The breathing patterns 
and body temperatures were monitored during application and the procedure was aborted 
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if either varied significantly from normal observations.  As a control, some animals did 
not undergo TMD induction procedures, and were just placed under 3% Isoflurane. 
During the period of study, if an animal experienced a subluxation of the TMJ, the animal 
was euthanized immediately to minimize pain and suffering. Upon successful application 
of mechanical stress, the retractor was released, removed, and the animal was allowed to 
recover in its original cage. 
Behavioral Testing 
For the nocifensive behavioral testing, animals were allowed to enter the Durham 
animal holding device (Ugo Basile, Italy) for five minutes on three consecutive days to 
acclimate the animals to the testing conditions essentially as described previously 
(Garrett et al., 2012, Hawkins et al., 2015, Hawkins and Durham, 2016). The animals 
were gently guided into the device and secured using a plastic blockade inserted behind 
the hind paws. To minimize false responses, animals were conditioned to a mechanical 
stimulus by gently rubbing the hair follicles and epidermis located over the masseter 
muscle and joint capsule with a pipette tip. Following acclimation period, mechanical 
nocifensive thresholds were determined in response to a series of calibrated von Frey 
filaments applied (North Coast Medical, Inc., Gilroy, CA; 26, 60, 100, 180, grams) in 
increasing force to the cutaneous area over the V1 area, masseter and joint capsule (Fig. 
5). The researcher responsible for directly testing the response to each filament was 
blinded to the experimental conditions. The filament was placed at the appropriate 
position and pressure was applied. If there is head withdrawal seen before bending of the 
filament, the response was considered as positive. The filament of interest for my study 
was the 100 gram filament since baseline positive responses to this force were 
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consistently less than one bilaterally, while the 180 gram regularly caused more than 
three out of five nocifensive head withdrawal responses per side.  Each filament was 
applied five times, and the data reported as the average number of responses obtained 
from five applications of each specific calibrated filament ± Standard Error of the Mean 
(SEM). Baseline thresholds were measured before experimental procedures. 
Measurements were also taken 2 hours, 1 day, 3 days, 5 days, 7 days, 14 days, 21 days 
and 28 days post-injury. On day 28, the animals are tested and then euthanized. Statistical 
analysis was performed on data with n = 8 or greater for each experimental condition. 
Outliers were determined by SPSS Statistics 21 software (IBM, North Castle, NY).  To 
determine normality of behavioral data sets, a Shapiro-Wilk test was utilized, while a 
Levene’s test was used to determine equal or unequal variance. It was determined that 
data sets were in violation of these assumptions and therefore non-parametric statistical 
analysis was used to determine significant changes. To determine if the observed effects 
were statistically significant, a  Kruskal-Wallis ANOVA was performed followed by a 
Mann-Whitney U post hoc test with a Bonferroni correction (αaltered = 0.05/6, P < 
0.008) for pairwise comparisons at each time point.  Additionally, a Friedman ANOVA 
was performed within each group, followed by a Wilcoxon Signed Ranks test with a 
Bonferroni correction (αaltered = 0.05/9, P < 0.006) to evaluate comparisons made in a 
single group from baseline readings. All statistical tests was conducted utilizing SPSS 
Statistics.  
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A) 
 
           B) 
           
Fig 3.  Induction of Prolonged Neck Muscle Inflammation.  (A) This figure depicts the 
ten different injection sites of CFA in the Trapezius muscle. (B) Image of the setup for 
anesthetizing the animals.   
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Fig. 4. Mechanically-Induced TMJ Injury Model. (A) Picture of lower jaw being 
retracted to near maximum jaw opening. (B) Animals resting in chamber after retraction 
distance was set. (C) Close-up image illustrating the position of retractor during 
procedure. (D) Picture of isoflurane control condition.  
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Fig. 5. Behavioral Testing Model.  (A) Adult Sprague-Dawley rat secured in Durham 
holding device. (B) An enlarged image showing the cutout area used to access regions of 
the head and face with arrows indicating the eyebrow, masseter, and capsule where 
pressure was applied to determine mechanical sensitivity. (C) Series of von Frey 
filaments used in my study. From left to right: 26 grams, 60 grams, 100 grams, and 180 
grams. 
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RESULTS 
 
 
 
Nocifensive Response to Mechanical Stimulation 
Baseline nocifensive thresholds were established for a series of force stimuli prior 
to either muscle injections or prolonged jaw opening. The data are reported as the number 
of reactions to the 60 gram force applied to the eyebrow of the V1 region and 100 gram 
force applied to the cutaneous area over the masseter and joint capsule of the V3 
dermatome of trigeminal nerve.  Responses to these filaments were reported because 
animals rarely respond to this force at baseline readings, whereas the subsequent higher 
force filaments always elicited a strong response. Once the average number of 
withdrawal responses for both right and left sides (5 each) was established, each animal 
was given a score based on the averages of the 10 total measurements. If the average was 
between 0-1.9 head withdrawal responses, these animals were given a score of one. If the 
number was between 2-2.9, they were given a score of two, if it was between 3-3.9, they 
were assigned a score of three, and it the average value was between 4-4.9, they were 
given a score of four. Animals that had an average value of 5 were given a score of five.   
Some animals went into an antinociception state and hence were not even responsive to 
the 180 g filaments. These animals were given the highest score of six. The score 
averages were calculated for each experimental group of animals. Animals were 
considered to have normal or mild sensitivity if they were in the 0-1.9 range, moderately 
sensitive if between 2-3.9 and severely sensitive if the average was greater than 4.  
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Masseter Region    
The average for the number of nocifensive head withdrawal responses to 
mechanical stimulation of the masseter in naïve male animals did not differ significantly 
between groups (Fig. 6A).  All values were in the normal or mild range (0-1.9) of 
sensitivity.  In contrast, the group of male animals that received CFA neck muscle 
injections (Fig. 7A) interestingly did not exhibit any significant differences in nocifensive 
behaviors in areas over the masseter muscles at the earlier time points but were elevated 
at days 5 and 7 days post muscle injections (p = 0.000).  The highest level of sensitivity 
was seen on day 5 with the value reaching the severe range (4-6).  However, by 14 days 
post injections, mechanical nocifensive sensitivity over the masseter muscles decreased 
and returned to near baseline mild levels by day 21.  As seen in Fig. 8A, prolonged jaw 
opening caused a change to moderate sensitivity at multiple time points but none of the 
values reached significance from basal levels.  There was a significant increase in 
trigeminal sensitivity in animals with neck muscle tension and prolonged jaw opening at 
multiple time points, with sustained moderate to severe sensitivity starting at day 1 and 
continuing into day 21 (Fig. 9A).   A summary of the results in nocifensive response to 
mechanical stimulation of the masseter muscle in male animals is shown in Fig. 10E.  
Similar to the males, no significant temporal change was observed in the sensitivity of the 
masseter in naïve (Fig. 6B). The female animals injected with CFA in the trapezius was 
significant on day 7 and exhibited moderate sensitivity at some time points (Fig. 7B).  A 
similar trend was seen in female animals subjected to prolonged jaw opening (Fig. 8B).  
In contrast, the combination of trapezius inflammation and prolonged jaw opening 
resulted in a significant change in the level of sensitivity starting on day 1 and continuing 
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in the severe range even at day 28, which was the longest time point recorded in my study 
(Fig. 9B).  A summary of the female results are presented in Fig. 10B.  My findings 
provide evidence that neck muscle tension/tenderness should be considered a risk factor 
for developing chronic pain in the masseter muscle following prolonged jaw opening in 
both male and female animals.  Furthermore, my results are suggestive that females may 
experience a more severe and longer-lasting state of pain and thus female gender should 
be considered a risk factor for chronic masseter sensitivity associated with TMD.    
 
TMJ Capsule 
The average for the number of nocifensive head withdrawal responses to 
mechanical stimulation of the TMJ capsule in naïve male animals did not differ 
significantly between groups (Fig. 11A). All the values were either in the mild or 
moderate sensitivity.  The group of animals that were treated with CFA injections in the 
trapezius muscle showed no significant difference to mechanical sensitivity at various 
different time points (Fig. 12A).   As seen in Fig. 13A, prolonged jaw opening caused a 
change to moderate sensitivity at multiple time points but none of the values reached 
significance from basal levels.  However, there was  a significant increase in trigeminal 
sensitivity in animals with neck muscle tension and prolonged jaw opening seen only at 
day 3, day 14 and  day 21 time points, with sustained moderate to severe sensitivity 
starting at day 1 and continuing into day 28 (Fig. 14A). A summary of the results in 
nocifensive response to mechanical stimulation of the TMJ capsule in male animals is 
shown in Fig. 15A.  Similar to the males, no significant temporal change was observed in 
the sensitivity of the TMJ capsule in naïve (Fig. 11B) or female animals injected with 
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CFA in the trapezius (Fig. 12B) even though CFA animals exhibited moderate sensitivity 
at some time points.  A similar trend was seen in female animals subjected to prolonged 
jaw opening where most of them showed mild or low moderate sensitivity (Fig. 13B).  In 
contrast, the combination of trapezius inflammation and prolonged jaw opening resulted 
in a significant change sensitivity on day 7 and day 28. The sensitivity started on day 3 
and continuing in the moderate range even at day 28, though the levels were not as 
consistently elevated at all time points (Fig. 14B).  A summary of the female results are 
presented in Fig. 15B.  My findings provide evidence that neck muscle tension/tenderness 
should be considered a risk factor for developing chronic pain in the TMJ capsule 
following prolonged jaw opening in both male and female animals.    
 
 
 V1 Region  
 
The average for the number of nocifensive head withdrawal responses to 
mechanical stimulation of the V1 dermatome above the eyebrow in naïve male animals 
did not differ significantly between groups (Fig. 16A). All the values were in the mild 
sensitivity.  The group of animals that were treated with CFA injections in the trapezius 
muscle showed no significant difference to mechanical sensitivity at various different 
time points (Fig. 17A).   As seen in Fig. 18A, prolonged jaw opening caused no change in 
sensitivity at any of the time points and only reached moderate levels on day 3.  
Somewhat surprisingly, there was no significant increase in trigeminal sensitivity in 
animals with neck muscle tension and prolonged jaw opening at any the time points (Fig. 
19A). A summary of the results in nocifensive response to mechanical stimulation of the 
V1 region in male animals is shown in Fig. 20A.  Similar to the males, no significant 
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temporal change was observed in V1 sensitivity in naïve (Fig. 16B) or female animals 
injected with CFA in the trapezius (Fig. 17B).  A similar trend was seen in female 
animals and no changes are seen in animals subjected to prolonged jaw opening (Fig. 
18B).  The combination of trapezius inflammation and prolonged jaw opening also failed 
to show any significant changes in the level of sensitivity (Fig. 19B).  A summary of the 
female results are presented in Fig. 20B.  My findings provide evidence that while neck 
muscle tension/tenderness and prolonged jaw opening resulted in a sustained state of 
nociception in the V3 dermatome regions, the masseter and TMJ capsule, the same risk 
factors did not mediate a change in trigeminal sensitivity in the V1 nerves.    
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Fig 6.  Temporal change in nocifensive head withdrawal responses to mechanical 
pressure applied to the cutaneous tissue over the masseter muscle in male and female 
naïve Sprague-Dawley rats.    
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Fig 7.  Temporal change in nocifensive head withdrawal responses to mechanical 
pressure applied to the cutaneous tissue over the masseter muscle in male and female 
muscle Sprague-Dawley rats.  Significant difference from the naïve animals is indicated 
by an asterisk. 
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Fig 8.  Temporal change in nocifensive head withdrawal responses to mechanical 
pressure applied to the cutaneous tissue over the masseter muscle in male and female jaw 
Sprague-Dawley rats.  Significant difference from the naïve animals is indicated by an 
asterisk. 
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Fig 9.  Temporal change in nocifensive head withdrawal responses to mechanical 
pressure applied to the cutaneous tissue over the masseter muscle in male and female 
muscle + jaw Sprague-Dawley rats.  Significant difference from the naïve animals is 
indicated by an asterisk. 
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Fig 10.  Summary of temporal change in nocifensive head withdrawal responses to 
mechanical pressure applied to the cutaneous tissue over the masseter muscle in male and 
female Sprague-Dawley rats.  Significant difference from the naïve animals is indicated 
by an asterisk. 
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Fig 11.  Temporal change in nocifensive head withdrawal responses to mechanical 
pressure applied to the cutaneous tissue over the TMJ capsule in male and female naive 
Sprague-Dawley rats.   
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Fig 12.  Temporal change in nocifensive head withdrawal responses to mechanical 
pressure applied to the cutaneous tissue over the TMJ capsule in male and female muscle 
Sprague-Dawley rats.  Significant difference from the naïve animals is indicated by an 
asterisk. 
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Fig 13.  Temporal change in nocifensive head withdrawal responses to mechanical 
pressure applied to the cutaneous tissue over the TMJ capsule in male and female jaw 
Sprague-Dawley rats.  Significant difference from the naïve animals is indicated by an 
asterisk. 
  
Normal/
Mild 
0 to 2
Moderate
2 to 4
Severe
4 to 6
Basal D8 Pre-
Jaw
2hr Post
Jaw
D1 Post
Jaw
D3 Post
Jaw
D5 Post
Jaw
D7 Post
Jaw
D14 Post
Jaw
D21 Post
Jaw
D28 Post
Jaw
Fig. 13 A Capsule Male Jaw (n=8)
Normal/
Mild 
0 to 2
Moderate
2 to 4
Severe
4 to 6
Basal D8 Pre-
Jaw
2hr Post
Jaw
D1 Post
Jaw
D3 Post
Jaw
D5 Post
Jaw
D7 Post
Jaw
D14 Post
Jaw
D21 Post
Jaw
D28 Post
Jaw
Fig. 13 B Capsule Female Jaw (n=8)
 34 
 
 
 
 
 
Fig 14.  Temporal change in nocifensive head withdrawal responses to mechanical 
pressure applied to the cutaneous tissue over the TMJ capsule in male and female muscle 
+ jaw Sprague-Dawley rats.  Significant difference from the naïve animals is indicated by 
an asterisk. 
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Fig 15.  Summary of temporal change in nocifensive head withdrawal responses to 
mechanical pressure applied to the cutaneous tissue over the TMJ capsule in male and 
female Sprague-Dawley rats.  Significant difference from the naïve animals is indicated 
by an asterisk. 
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Fig 16.  Temporal change in nocifensive head withdrawal responses to mechanical 
pressure applied to the cutaneous tissue over the eyebrow region that is innervated by V1 
trigeminal neurons in male and female naive Sprague-Dawley rats.  
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Fig 17.  Temporal change in nocifensive head withdrawal responses to mechanical 
pressure applied to the cutaneous tissue over the eyebrow region that is innervated by V1 
trigeminal neurons in male and female muscle Sprague-Dawley rats. Significant 
difference from the naïve animals is indicated by an asterisk. 
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Fig 18.  Temporal change in nocifensive head withdrawal responses to mechanical 
pressure applied to the cutaneous tissue over the eyebrow region that is innervated by V1 
trigeminal neurons in male and female jaw Sprague-Dawley rats. Significant difference 
from the naïve animals is indicated by an asterisk. 
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Fig 19.  Temporal change in nocifensive head withdrawal responses to mechanical 
pressure applied to the cutaneous tissue over the eyebrow region that is innervated by V1 
trigeminal neurons in male and female muscle + jaw Sprague-Dawley rats. Significant 
difference from the naïve animals is indicated by an asterisk. 
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Fig 20.  Summary of temporal change in nocifensive head withdrawal responses to 
mechanical pressure applied to the cutaneous tissue over the eyebrow region that is 
innervated by V1 trigeminal neurons in male and female Sprague-Dawley rats. 
Significant difference from the naïve animals is indicated by an asterisk. 
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DISCUSSION 
 
 
A major novel finding from my study was that muscle inflammation prior to 
prolonged jaw opening was sufficient to promote development of a state of chronic 
nociception that was more severe and of greater duration in female animals.  My results 
are in agreement with data from the NIH funded OPPERA study in which jaw injury, 
neck/shoulder muscle tension and tenderness, and female gender were strongly associated 
with development of chronic TMD in humans (Ohrbach et al., 2011a).  Unfortunately, 
prolonged jaw opening, which can occur during yawning, or normal orthodontic and 
dental procedures, can lead to persistent inflammation and pain in the TMJ itself or in the 
surrounding muscles.  The foundation for my study was based on a published procedure 
developed by the Durham lab that involved the use of a retractor to hold open the jaw of 
young adult male Sprague-Dawley rats to near maximal without causing subluxation of 
the joint (Hawkins and Durham, 2016).  In that study, prolonged jaw opening for 20 
minutes resulted in a sustained increase in the nocifensive response to mechanical 
stimulation of trigeminal neurons that resolved by around 14 days.  In my study, I wanted 
to test the hypothesis that neck muscle tension caused by low-grade inflammation in the 
trapezius would act as a risk factor to increase the likelihood of a more severe and longer-
lasting state of nociception.  In addition, I thought that female animals may be more 
susceptible to both types of risk factors given the higher prevalence of chronic TMD 
reported by female individuals in the United States (Bonjardim et al., 2009).  My findings 
could have important implications for dentists, orthodontists, and other health care 
professionals that provide dental care to patients.  Based on my results, I would 
recommend that patients be evaluated for ongoing neck and shoulder tenderness/pain 
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prior to performing a dental procedure, especially if it will require near maximal jaw 
opening for a prolonged period of time such as during molar extractions.  Being a dentist 
myself, I would recommend that if a patient is experiencing neck muscle 
stiffness/discomfort that the amount of time the mouth is held open to near maximum 
should be limited with sufficient rest periods to minimize harm to the TMJ and associated 
tissues.  Furthermore, female patients should be carefully evaluated for ongoing neck 
muscle pathology and if severe enough, it may be prudent to not perform the procedure 
given the increased risk for developing chronic TMD pain.  To my knowledge, my 
findings provide the first evidence to support the notion that neck muscle inflammation 
and female gender increase the risk of chronic TMD following prolonged jaw opening.    
In agreement with my findings, neck muscle tension or tenderness to palpation is 
often reported as a risk factor for TMD, migraine, and other orofacial pain conditions that 
involve sensitization of trigeminal nociceptive neurons (Ohrbach et al., 2011b).  
Interestingly, skeletal muscles have been referred to as a silent organ since often times 
one does not even know there is ongoing tension and inflammation until someone 
touches the specific region and hits a taut band of muscle fibers.  Results from my study 
provide evidence that low-grade sustained inflammation of the trapezius is sufficient to 
promote sensitization of trigeminal neurons.  This level of inflammation did not appear to 
negatively affect the animal’s ability to eat, drink, or move about the cage, but was 
associated with a lowering of the activation threshold of primary trigeminal nociceptors.  
A likely explanation for this sensitizing effect is that centrally-projecting nerve fibers 
from the dorsal root ganglion neurons innervating the trapezius localize to the same 
region in the upper spinal cord as the efferent fibers from all branches of the trigeminal 
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ganglion (Sessle, 1999). Thus, there is a convergence of sensory nerve fibers projecting 
from the trapezius and ganglion such that cross communication is possible to modulate 
the effect on second order nociceptive neurons and promote central sensitization.  This 
type of interaction would facilitate a coordinated response to potentially harmful noxious 
stimuli.  One of the molecules that likely plays a key role in promoting sensitization of 
the second order neurons is the neuropeptide calcitonin gene-related peptide (CGRP) 
(Seybold, 2009), which is released in the spinal cord upon activation of the dorsal root 
ganglion neuron providing innervation to the trapezius.  Recent findings from our lab 
have demonstrated that elevated levels of CGRP can cause central and peripheral 
sensitization of trigeminal neurons via a protein kinase A dependent mechanism 
(Cornelison et al., 2016).  Thus, bidirectional signaling with the upper spinal cord is 
likely responsible for the increased sensitivity of trigeminal neurons that provide 
innervation to the muscles, ligaments, and tendons involved in jaw movements. Based on 
my findings, I propose that unresolved neck muscle tension/inflammation would lead to a 
sensitized state of both spinal and ganglion trigeminal nociceptors, and hence an 
increased risk for development of a chronic pain state in response to prolonged jaw 
opening.   
Females are more likely to seek medical treatment for orofacial pain conditions 
and report greater pain scores.  In my study, I found that sensitized male and female 
animals were susceptible to prolonged nociception in the TMJ capsule and masseter 
following jaw opening but female animals exhibited a more consistently high level of 
nociception for a longer duration.  With respect to TMD, females are more than 2 times 
more likely to report symptoms when compared to age matched males.  While hormonal 
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differences related to the menstrual cycle may account for why the female rats were more 
sensitized (Nekora-Azak, 2004, Cairns, 2010), I did not observe changes in the level of 
sensitization in the naïve female animals during any time in my study.  As an alternative 
explanation, the greater degree of nociception observed in the females following 
prolonged jaw opening may be due to anatomical differences in the structures of the jaw 
and associated tissues involved in mastication.  In my model, near maximal jaw opening 
for 20 minutes may cause a more prolonged and severe form of injury to the ligaments 
and tendons and possibly even the masseter muscle given the smaller size of these 
structures.  It will be of interest in future studies to investigate the relative level of 
inflammation in these tissues using the method involving Evan’s Blue.  The dye is 
injected in the tail vein and allowed to circulate for 10 minutes.  Wherever there is 
ongoing peripheral inflammation characterized by protein plasma extravasation 
(leakage), this large dye will localize and then can be detected via visual observation and 
quantitated by measuring its absorbance with a spectrophotometer.   
Another goal of my study was to compare the sensitivity level in tissues 
innervated by different branches of the trigeminal ganglion in response to prolonged jaw 
opening in sensitized animals.  While both the TMJ and masseter muscle are innervated 
by the V3 or mandibular branch of the trigeminal ganglion nerves, the cutaneous tissue 
over the eyebrow is innervated by sensory fibers emanating from the V1 branch.  Prior to 
my study, I had predicted that the nocifensive response would be similar in all the tissues 
given that results from prior studies had demonstrated cross-excitation of all the branches 
following activation in one branch (Thalakoti et al., 2007, Damodaram et al., 2009).  
However, the level of nociception was greatest over the masseter muscle with 
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comparable levels over the TMJ capsule, which supports the notion that neck muscle 
tension may be more closely associated with TMD pathology since the activity of the 
head and neck muscles needs to be coordinated during mastication.  The rationale for 
studying changes in the sensitivity level in V1 neurons is based on reports that TMD 
pathology is often co-morbid with migraine (Ballegaard et al., 2008, Bevilaqua Grossi et 
al., 2009, Dahan et al., 2015).  While prolonged jaw opening did not elicit a sustained 
nocifensive response from V1 neurons, it is likely that these nerves are still in a sensitized 
state characterized by a lower threshold of activation to other stimuli.  In support of this 
notion, I conducted a pilot study using an extract of California Bay leaves, which is 
known to cause excitation of V1/V2 trigeminal neurons (Nassini et al., 2012), as a 
triggering factor in day 28 animals that were in a chronic pain state.  In these animals, 
exposure to this pungent odor was sufficient to cause a robust nocifensive response that 
was greater in intensity when compared to even the neck muscle sensitized, jaw injury 
animals.  Thus, results from my pilot study provided evidence that ongoing TMD 
pathology should be considered a risk factor for inducing V1 trigeminal activation, which 
is a key physiological feature of migraine attacks.  
While I focused on understanding the changes in nociception in my model, there 
are many unanswered questions that would be of interest to pursue in future studies.  In 
particular, immunohistochemistry could be used to determine cellular changes in the 
expression of key proteins in the trigeminal ganglion and spinal trigeminal nucleus that 
are implicated in peripheral and central sensitization, respectively.  Proteins of interest 
that are likely to be upregulated in neuronal cells include CGRP, protein kinase A, and 
the MAP kinases – ERK, JNK, and p38 (Ji, 2004, Seybold, 2009).  In addition, I would 
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expect that sustained activation of glial cells in the trigeminal ganglion and spinal cord 
will temporally correlate with increased nociception (Ji et al., 2013).  Another area that 
would be of interest to explore would be the effects on biopsychosocial behaviors in my 
model of chronic TMD.  Given the severity and duration of the nociceptive response, it is 
likely that female animals will exhibit decreases in cognitive function (novel object 
recognition), anxiety levels (elevated maze), and social interactions.  Although not 
included in my thesis project, I helped to develop these assays in out laboratory and 
believe results from these studies would provide important translational information to 
clinicians.  TMD is commonly characterized by comorbidities; including 
headache/migraine, back pain, widespread pain and fibromyalgia, and psychosocial 
challenges including depression, anxiety, and multiple nonspecific physical symptoms 
(Aaron et al., 2000, Dahan et al., 2015).  Often TMD is characterized by impairment in 
daily activities, excess reliance on health care, and dependence on narcotic analgesics 
(Hersh et al., 2008).  Thus, based on the study of Dworkin and colleagues (Suvinen et al., 
2005), patients with TMJD should be evaluated according to both the physical disorder 
and the psychosocial illness impact factors. Only through using an integrated and 
multidimensional approach concerning physical and psychosocial factors 
in TMJ pain and dysfunction will successful management of TMD be achievable by 
reducing the disease burden.  Furthermore, another area that would be important to 
investigate is the potential of a non-pharmacological therapeutic to decrease nociception 
as well as the disease burden mediated by prolonged trigeminal nociception.   
Given the prevalence, significant morbidity, and major social and economic 
ramifications of TMD, there is a critical need for improved therapeutic and preventative 
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measures for TMD.  Although much work has been done to identify the key molecules 
whose levels are elevated during TMJ and masseter inflammation and pain, few novel 
therapeutic strategies to treat TMD have resulted from these studies.  Furthermore, 
chronic inflammatory pain associated with TMD can persist for months or even years 
after the primary tissue damage has healed, and current treatments with steroids and COX 
inhibitors have only produced limited relief of this pain in a portion of patients and are 
frequently associated with significant adverse effects (Cairns, 2010).  A potential reason 
for the lack of specific therapies may be due to the limitations of the previous animal 
models of TMD pathology, which relied on injection of inflammatory agents in the 
masseter or TMJ capsule.  Interestingly, none of the prior animal models results in a 
sustained or chronic state of nociception.  In contrast, my model, which more closely 
mimics the pathophysiological events associated with human TMD, can be utilized in 
future studies to identify novel cellular targets for inhibiting the development of 
peripheral and central sensitization.  I am particularly interested in knowing the effect of 
treatment with monoclonal antibodies against CGRP on nociception and behavioral 
responses in my model since they are in development for chronic migraine.  However, 
there still remains a great need for the identification of novel modalities to more 
effectively manage the pathological events associated with TMD.  One approach towards 
this goal is to utilize natural products to modulate CGRP levels in the spinal cord and 
ganglion. The use of nutraceuticals is increasing in the general population and health care 
providers are often questioned by patients about the use of more “natural” treatments. 
The use of natural products offers a novel method for preventing and treating chronic 
inflammatory diseases (Vuorelaa et al., 2004, Newman and Cragg, 2007).  In support of 
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this notion, we have provided evidence that inclusion of GSE in the diet of rats was 
sufficient to cause upregulation of the anti-inflammatory protein MKP-1 and suppress 
CGRP expression in the STN, and repress the stimulatory effects of CFA injection into 
the TMJ on expression of active p38, OX-42, and GFAP (Cady et al., 2010).  Results 
from our study provide evidence that dietary inclusion of GSE would be beneficial as a 
natural therapeutic option for TMJD by suppressing development of peripheral and 
central sensitization.  Another therapeutic approach may involve the injection of small 
amounts of botulinum toxin type A (BOTOX) into the trapezius to determine if reducing 
the tension will prevent the development of a sensitized state of trigeminal neurons.  In 
conclusion, I believe that my model will be useful for further understanding at the 
cellular level the transition from an episodic to a chronic pain state and provide a 
clinically relevant model for identification of novel therapies for managing TMD. 
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